{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:03:47Z","timestamp":1790283827702,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020908","name":"Pfizer SAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.resmer.2026.101320","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:46:44Z","timestamp":1787932004000},"page":"101320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differences in influenza and pneumococcal vaccination coverage according to chronic respiratory diseases during the COVID-19 pandemic in France: a nationwide cohort study using the French national health data system"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-5033","authenticated-orcid":false,"given":"Nicolas","family":"Roche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2373-1872","authenticated-orcid":false,"given":"Benjamin","family":"Grenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Raguideau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Vacheret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenael","family":"Goussiaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wyplosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2026.101320_bib0001","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijid.2021.12.365","article-title":"Risk factors for pneumococcal disease in persons with chronic medical conditions: results from the LIFE study","volume":"116","author":"Fukuda","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resmer.2026.101320_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad192","article-title":"Risk of pneumococcal disease in US adults by age and risk profile","volume":"10","author":"Grant","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.resmer.2026.101320_bib0003","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/1469-0691.12182","article-title":"Invasive pneumococcal disease in patients with an underlying pulmonary disorder","volume":"19","author":"Inghammar","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resmer.2026.101320_bib0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12890-023-02497-2","article-title":"Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study","volume":"23","author":"Ochoa-Gondar","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resmer.2026.101320_bib0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-018-3326-z","article-title":"Clinical and economic burden of pneumococcal disease in US adults aged 19\u201364 years with chronic or immunocompromising diseases: an observational database study","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resmer.2026.101320_bib0006","first-page":"CD010115","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","volume":"2014","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2026.101320_bib0007","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1513\/AnnalsATS.202103-414RL","article-title":"Inhaled corticosteroid use and invasive pneumococcal pneumonia","volume":"19","author":"Tor\u00e9n","year":"2022","journal-title":"Annals ATS"},{"key":"10.1016\/j.resmer.2026.101320_bib0008","first-page":"A25","volume":"12","author":"Burgel","year":"2020","journal-title":"Rev Mal Respi Actual"},{"key":"10.1016\/j.resmer.2026.101320_bib0009","series-title":"Medical and biomedical updates","first-page":"55","article-title":"Pneumococcal vaccine in adult asthma patients","author":"Czaicki","year":"2021"},{"key":"10.1016\/j.resmer.2026.101320_bib0010","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.rmr.2022.01.014","article-title":"Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique \u2013 actualisation 2021. Version int\u00e9grale","volume":"39","author":"Cottin","year":"2022","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.resmer.2026.101320_bib0011","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.rmr.2021.02.070","article-title":"Optimisation du traitement m\u00e9dicamenteux des patients atteints de BPCO en \u00e9tat stable. Position de la soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise. Actualisation 2021","volume":"38","author":"Zysman","year":"2021","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.resmer.2026.101320_bib0012","first-page":"A1","article-title":"Guide pratique de vaccination en pneumologie","volume":"12","author":"Blanchard","year":"2020","journal-title":"Rev Mal Respir Actual"},{"key":"10.1016\/j.resmer.2026.101320_bib0013","first-page":"e1","article-title":"Guide pratique de vaccination en pneumologie : actualisation 2024","volume":"16","author":"Blanchard","year":"2024","journal-title":"Rev Mal Respir Actual"},{"key":"10.1016\/j.resmer.2026.101320_bib0014","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Avis relatif aux recommandations de la vaccination pour les adultes et les enfants \u00e2g\u00e9s de plus de 2 ans \u00e0 risque d\u2019infection invasive \u00e0 pneumocoque. Paris; 2013. http:\/\/www.hcsp.fr\/Explore.cgi\/avisrapportsdomaine?clefr=355. [Accessed 10 December 2024]."},{"key":"10.1016\/j.resmer.2026.101320_bib0015","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Avis relatif aux recommandations vaccinales contre les infections \u00e0 pneumocoque pour les adultes 2017. https:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=614. [Accessed 10 December 2024]."},{"key":"10.1016\/j.resmer.2026.101320_bib0016","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1016\/j.vaccine.2022.06.071","article-title":"Pneumococcal and influenza vaccination coverage among at-risk adults: a 5-year French national observational study","volume":"40","author":"Wyplosz","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.resmer.2026.101320_bib0018","unstructured":"Minist\u00e8re du travail de la sant\u00e9, et des solidarit\u00e9s. Calendrier des vaccinations et recommandations. vaccinales 2024:2024. https:\/\/sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal. [Accessed 10 December 2024]."},{"key":"10.1016\/j.resmer.2026.101320_bib0020","unstructured":"Minist\u00e8re du travail, de la sant\u00e9, et des solidarit\u00e9s. Calendrier des vaccinations et recommandations. vaccinales 2024:2024. https:\/\/sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal. [Accessed 10 December 2024]."},{"key":"10.1016\/j.resmer.2026.101320_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329703","article-title":"Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: a retrospective population-based study in France","volume":"20","author":"Wyplosz","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.resmer.2026.101320_bib0022","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.resmer.2026.101320_bib0023","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resmer.2026.101320_bib0024","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.resmer.2026.101320_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.759602","article-title":"Pneumococcal vaccination coverage and uptake among adults in Switzerland: a nationwide cross-sectional study of vaccination records","volume":"9","author":"Zens","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.resmer.2026.101320_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106207","article-title":"Use of pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany","volume":"174","author":"Mohr","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2026.101320_bib0027","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/vaccines10020311","article-title":"Low adherence to pneumococcal vaccination in lung cancer patients in a tertiary care university hospital in southern Germany","volume":"10","author":"Mohr","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.resmer.2026.101320_bib0028","article-title":"Influenza and pneumococcal vaccination in patients with COPD from 3 French cohorts: insufficient coverage and associated factors","volume":"86","author":"Raherison","year":"2024","journal-title":"Respir Med Res"},{"key":"10.1016\/j.resmer.2026.101320_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107606","article-title":"Prevalence and disparities in influenza vaccination among patients with COPD: a French nationwide population study","volume":"226","author":"Zysman","year":"2024","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2026.101320_bib0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1186\/s12879-022-07736-1","article-title":"Pneumococcal vaccination coverage in individuals (16\u201359 years) with a newly diagnosed risk condition in Germany","volume":"22","author":"Deb","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resmer.2026.101320_bib0031","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/14760584.2023.2226718","article-title":"Pneumococcal vaccination coverage among US adults enrolled in medicaid and newly diagnosed with underlying medical conditions","volume":"22","author":"Liu","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.resmer.2026.101320_bib0032","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1186\/s12889-020-09613-5","article-title":"Pneumococcal vaccine coverage among individuals aged 18 to 64 years old with underlying medical conditions in the UK: a retrospective database analysis","volume":"20","author":"Matthews","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.resmer.2026.101320_bib0033","unstructured":"D\u00e9cret n\u00b0 2023-736 du 8 ao\u00fbt 2023 relatif aux comp\u00e9tences vaccinales des infirmiers, des pharmaciens d\u2019officine, des infirmiers et des pharmaciens exer\u00e7ant au sein des pharmacies \u00e0 usage int\u00e9rieur, des professionnels de sant\u00e9 exer\u00e7ant au sein des laboratoires de biologie m\u00e9dicale et des \u00e9tudiants en troisi\u00e8me cycle des \u00e9tudes pharmaceutiques - L\u00e9gifrance, https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000047948973"},{"key":"10.1016\/j.resmer.2026.101320_bib0034","article-title":"Guide du parcours de soins bronchopneumopathie chronique","year":"2019","journal-title":"obstructive"},{"key":"10.1016\/j.resmer.2026.101320_bib0035","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 HAS. Mucoviscidose.Guide maladie chronique. Saint-Denis. LaPlaine2025. https:\/\/has-sante.fr\/jcms\/c_2792719\/fr\/mucoviscidose."},{"key":"10.1016\/j.resmer.2026.101320_bib0036","unstructured":"RespiFIL - Fili\u00e8re de sant\u00e9 des maladies respiratoires rares. Protocoles nationaux de diagnostic et de soins (PNDS). 2020 https:\/\/respifil.fr\/professionnels\/protocoles-nationaux-de-diagnostic-et-de-soins-pnds\/. [Accessed 10 December 2024]."},{"key":"10.1016\/j.resmer.2026.101320_bib0037","doi-asserted-by":"crossref","first-page":"ckz185.375","DOI":"10.1093\/eurpub\/ckz185.375","article-title":"The organization and delivery of vaccination services in the European Union","volume":"29","author":"Rechel","year":"2019","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.resmer.2026.101320_bib0038","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.2024.21060","article-title":"Electronic nudges to increase influenza vaccination in patients with chronic diseases: a randomized clinical trial","volume":"332","author":"Johansen","year":"2024","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.resmer.2026.101320_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.idnow.2021.07.006","article-title":"Adults at risk of pneumococcal disease in France","volume":"51","author":"Wyplosz","year":"2021","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.resmer.2026.101320_bib0046","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MLR.0000000000001745","article-title":"The economic burden of disease in France from the national health insurance perspective: the healthcare expenditures and conditions mapping used to prepare the French social security funding act and the public health act","volume":"60","author":"Rachas","year":"2022","journal-title":"Med Care"},{"key":"10.1016\/j.resmer.2026.101320_bib0047","article-title":"Identification et estimation de la pr\u00e9valence de l\u2019asthme s\u00e9v\u00e8re en France via l\u2019\u00e9chantillon g\u00e9n\u00e9raliste de b\u00e9n\u00e9ficiaires","volume":"66","author":"Bou\u00e9e","year":"2018","journal-title":"Rev Epid\u00e9miol Sante Publique"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:53:21Z","timestamp":1790283201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041226000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"alternative-id":["S2590041226000747"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101320","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in influenza and pneumococcal vaccination coverage according to chronic respiratory diseases during the COVID-19 pandemic in France: a nationwide cohort study using the French national health data system","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101320"}}